Hugel, Inc.

₩187,500As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:145020Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 5.06%
Div yield —
ROE 16.53%
Biotechnology
Beta (5Y) 0.49
PE TTM 16.26
TSR TTM (28.44%)
Mkt cap ₩2.026T
ROIC 32.38%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩203,215
8.38%
(49.84%)
Hold 3|7|1|9|0
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
1,614
1,603
1,632
1,566
1.29%
4.43%
0.69%
(7.05%)
Revenue₩B
102.3
101.7
103.2
100.9
7.73%
10.16%
7.86%
2.86%
Peers (US$1.493B)
Cap (US$)
PE
1.673B
—
1.488B
—
Capital
TTM
5Y
10Y
Leveragex
0.768
(0.253)
(0.211)
EBIT/Intx
0.698
1.677
1.684
Own earn%
(60.31)
(11.15)
(12.43)
Sh yield%
46.47
33.42
36.90
Owners
Insiders/Inst%
0.61
73.96
Short interest%
1.33
SBC / revenue%
0.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
24–31
$1 testx
−0.1
Incr. ROIC%
7